Over a week ago |
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 03/14/23
- Vacasa says finished 2022 with 44K homes on platform, up 19% from 2021
- 01/24/23
- Vacasa to cut about 1,300 jobs or 17% of workforce, affirms Q4 guidance
- 10/02/22
- Fly Intel: Top five weekend stock stories
- $116.29 /
-0.815 (-0.70%) - 02/27/23
- Steel Dynamics increases quarterly dividend 25% to 42.5c per share
- 02/09/23
- Steel Dynamics names Barry Schneider COO
- 12/22/22
- Steel Dynamics to replace Abiomed in S&P 500 at open on 12/22
- 12/22/22
- Super Micro Computer to replace Steel Dynamics in S&P 400 at open on 12/22
- 03/13/23
- Sportradar wins bid for ATP data, betting streaming rights
- 02/01/23
- Sportradar appoints Riviere as Chief People Officer
- 11/09/22
- SharpLink Gaming appoints Dave Abbott as CTO
- 10/26/22
- Sportradar enters long-term agreement with FanDuel for official NBA data
- 03/14/23
- Smartsheet names Mike Gregoire board chair
- 12/02/22
- Smartsheet rises 15.6%
- 12/02/22
- Smartsheet rises 13.6%
- 12/01/22
- Smartsheet jumps 8% to $35.35 after Q3 earnings beat, guidance raise
- 03/01/23
- Royalty Pharma appoints Ashwin Pai as EVP, investments
- 02/15/23
- Royalty Pharma sees FY23 adjusted cash receipts view $2.375B-$2.475B
- 01/09/23
- Royalty Pharma provides business update, outlook
- 01/09/23
- Royalty, Ionis enter into royalty agreement for up to $1.1B
- 03/06/23
- Ranpak Holdings falls -12.7%
- 10/20/22
- Ranpak Holdings rises 9.7%
- 03/15/23
- Oatly Group expects gross profit margin 35%-40% in longer-term
- 03/15/23
- Oatly Group expects positive adjusted EBITDA for FY24
- 03/15/23
- Oatly Group announces financing commitments of $425M
- 03/06/23
- Oatly Group announces results of 2023 Extraordinary General Meeting
- 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 11/03/22
- Sanara MedTech enters InfuSystem wound therapy partnership
- 11/03/22
- Sanara MedTech, InfuSystem announce wound therapy partnership
- 11/03/22
- InfuSystem and Sanara MedTech announce wound therapy partnership
- 03/15/23
- Halozyme provides update on EPO decision regarding Darzalex
- 03/01/23
- Halozyme director Henderson sells 20,000 common shares
- 01/10/23
- Halozyme falls 7% to $52.00 after below-consensus FY23 guidance
- 01/10/23
- Halozyme announces anticipated key events in 2023
- 02/22/23
- Ebix signs debt extension amendment with existing lenders
- 02/21/23
- Ebix hosts North American customer conference in Orlando, Florida
- 02/14/23
- Ebix becomes first to launch UPI for foreign nationals visiting India
- 02/07/23
- Ebix reports 'record volumes' on AnnuityNet4 in 2022
- 03/15/23
- Credit Suisse falls 20% after top holder says not investing more
- 03/14/23
- Credit Suisse finds 'material weaknesses' in financial reporting controls
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/16/23
- Stifel Financial announces launch of an ASPG, new hires
- 03/15/23
- Circor 'continues to progress' with review of strategic alternatives
- 02/22/23
- Circor sees Q4 orders $248.8M
- 11/14/22
- Circor rises 20.9%
- 11/14/22
- Circor rises 12.0%
- 01/30/23
- Babcock & Wilcox awarded $15M in contracts for waste-to-energy plants in UK
- 01/24/23
- Babcock & Wilcox awarded $65M contract for UK waste-to-energy plant
- 01/11/23
- Babcock & Wilcox awarded contract to support Phillips 66 project in U.K.
- 12/13/22
- Babcock & Wilcox awarded $20M contract for ash-handling technologies
- 11/01/22 Craig-Hallum
- Craig-Hallum lowers Ranpak target to $7, recommends investors accumulate stock
- 05/09/22 Craig-Hallum
- Ranpak Holdings price target lowered to $19 from $35 at Craig-Hallum
- 05/09/22 Baird
- Ranpak Holdings price target lowered to $20 from $38 at Baird
- $116.29 /
-0.815 (-0.70%) - 03/15/23 Citi
- Steel Dynamics downgraded to Neutral from Buy at Citi
- 03/14/23 BMO Capital
- Steel Dynamics transferred with a Market Perform rating at BMO Capital
- 01/27/23 BMO Capital
- Steel Dynamics price target raised to $120 from $109 at BMO Capital
- 01/27/23 Goldman Sachs
- Steel Dynamics downgraded to Neutral from Buy at Goldman Sachs
- 09/06/22 Morgan Stanley
- Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
- 07/28/22 Citi
- Royalty Pharma price target raised to $60 from $50 at Citi
- 07/14/22 Tigress Financial
- Royalty Pharma price target raised to $57 from $52 at Tigress Financial
- 06/13/22 UBS
- Royalty Pharma initiated with a Buy at UBS
- 03/15/23 RBC Capital
- Smartsheet price target raised to $43 from $36 at RBC Capital
- 03/15/23 DA Davidson
- Smartsheet price target raised to $57 from $54 at DA Davidson
- 03/15/23 BMO Capital
- Smartsheet price target raised to $50 from $41 at BMO Capital
- 03/15/23 Canaccord
- Smartsheet price target raised to $50 from $45 at Canaccord
- 12/09/22 Citi
- Circor price target raised to $28 from $26 at Citi
- 08/18/22 Citi
- Circor price target raised to $21 from $19 at Citi
- 08/11/22 KeyBanc
- Circor price target lowered to $27 from $37 at KeyBanc
- 04/18/22 Stifel
- Circor price target lowered to $36 from $41 at Stifel
- 01/09/23 Jefferies
- Sportradar downgraded to Hold at Jefferies as focus narrows
- 01/09/23 Jefferies
- Sportradar downgraded to Hold from Buy at Jefferies
- 11/23/22 Deutsche Bank
- Sportradar price target lowered to $14 from $16 at Deutsche Bank
- 11/21/22 Morgan Stanley
- Sportradar initiated with an Equal Weight at Morgan Stanley
- 01/18/23 Mizuho
- Oatly Group upgraded to Buy at Mizuho with bearish sentiment at peak
- 01/18/23 Mizuho
- Oatly Group upgraded to Buy from Neutral at Mizuho
- 01/10/23 Piper Sandler
- Oatly Group price target raised to $4 from $3 at Piper Sandler
- 11/21/22 TD Cowen
- Oatly Group price target lowered to $3 from $5 at Cowen
- 10/28/22 B. Riley
- Babcock & Wilcox price target lowered to $8 from $12.50 at B. Riley
- 07/19/22 Craig-Hallum
- Babcock & Wilcox initiated with a Buy at Craig-Hallum
- 02/23/23 Craig-Hallum
- Ebix price target lowered to $40 from $150 at Craig-Hallum
- 06/17/22 Craig-Hallum
- Ebix has 'long history' of disproving shorts, says Craig-Hallum
- 12/21/22 Morgan Stanley
- Halozyme assumed with an Overweight at Morgan Stanley
- 12/08/22 Benchmark
- Halozyme price target raised to $68 from $55 at Benchmark
- 11/28/22 Wells Fargo
- Halozyme initiated with an Overweight at Wells Fargo
- 09/09/22 Morgan Stanley
- Halozyme initiated with an Overweight at Morgan Stanley
- 03/15/23 Northland
- Vacasa price target lowered to $2.50 from $5 at Northland
- 03/15/23 Oppenheimer
- Vacasa downgraded to Perform at Oppenheimer on elevated churn issues
- 03/15/23 Needham
- Vacasa price target lowered to $1.50 from $5.00 at Needham
- 03/15/23 Oppenheimer
- Vacasa downgraded to Perform from Outperform at Oppenheimer
- 03/15/23 Northland
- Luna Innovations downgraded to Market Perform from Outperform at Northland
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 03/10/23 GLJ Research
- Sunrun has lost two largest lenders in 90 days, says GLJ Research
- 02/16/23 Citi
- Credit Suisse downgraded at Citi on franchise erosion and poor visibility
- 02/16/23 Citi
- Credit Suisse downgraded to Neutral from Buy at Citi
- 02/13/23 Kepler Cheuvreux
- Kepler downgrades Credit Suisse to Reduce on earnings concerns
- 03/14/23
- Vacasa sees FY23 revenue down mid to high single digits
- 03/14/23
- Vacasa sees Q1 revenue $230M-$240M, consensus $264.8M
- 03/14/23
- Vacasa reports Q4 EPS (70c), consensus (38c)
- 11/09/22
- Vacasa reports Q3 EPS 4c, consensus 7c
- $116.29 /
-0.815 (-0.70%) - 03/15/23
- Steel Dynamics sees Q1 adjusted EPS $3.78-$3.82, consensus $3.11
- 01/25/23
- Steel Dynamics reports Q4 adjusted EPS $4.37, consensus $3.79
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 03/15/23
- Sportradar sees FY23 revenue $965.1M-$984.4M, consensus $936.11M
- 03/15/23
- Sportradar reports Q4 revenue $220.7M, consensus $208.09M
- 11/16/22
- Sportradar raises FY22 revenue view EUR 718M-EUR 723M from EUR 695M-EUR 715
- 11/16/22
- Sportradar reports Q3 revenue $175.2M, consensus $176.31M
- 03/14/23
- Smartsheet sees FY24 adjusted EPS 31c-38c, consensus (9c)
- 03/14/23
- Smartsheet sees Q1 adjusted EPS 8c-9c, consensus (6c)
- 03/14/23
- Smartsheet reports Q4 adjusted EPS 7c, consensus (1c)
- 03/14/23
- Notable companies reporting after market close
- 03/15/23
- Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B
- 02/15/23
- Royalty Pharma reports Q4 revenue $566M vs $576M last year
- 11/08/22
- Royalty Pharma raises FY22 adjusted cash receipts view to $2.75M-$2.8M
- 11/08/22
- Royalty Pharma reports Q3 revenue $573M, consensus $587.17M
- 03/15/23
- Ranpak Holdings sees FY23 revenue $365M - $385M, consensus $359.8M
- 03/15/23
- Ranpak Holdings reports Q4 net loss $7.3M vs $2.5M last year
- 11/01/22
- Ranpak Holdings reports Q3 EPS (11c), consensus (15c)
- 03/15/23
- Oatly Group sees 2023 revenue growth 23%-28%, consensus $886.11M
- 03/15/23
- Oatly Group reports Q4 EPS (21c), consensus (14c)
- 11/14/22
- Oatly Group sees FY22 revenue $700M-$720M, consensus $798.58M
- 11/14/22
- Oatly Group reports Q3 EPS (18c), consensus (11c)
- 03/14/23
- Luna Innovations sees FY23 revenue $125M-$130M, consensus $129.8M
- 03/14/23
- Luna Innovations sees Q1 revenue $23.0M-$25.0M, consensus $26.5M
- 03/14/23
- Luna Innovations reports Q4 EPS 8c, consensus 9c
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 03/15/23
- InfuSystem sees FY23 revenue $118M-$121M, consensus $122.6M
- 03/15/23
- InfuSystem reports Q4 EPS 1c, consensus 4c
- 11/08/22
- InfuSystem sees FY22 revenue $112M, consensus $112.67M
- 11/08/22
- InfuSystem reports Q3 EPS 2c, consensus 1c
- 03/15/23
- Halozyme reaffirms FY23 revenue view $815M-$845M, consensus $829.01M
- 02/21/23
- Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.78
- 02/21/23
- Halozyme reports Q4 adjusted EPS 48c, consensus 47c
- 01/10/23
- Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.90
- 03/15/23
- Ebix reports Q4 adjusted EPS 36c
- 11/09/22
- Ebix reports Q3 EPS 59c vs 50c last year
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/15/23
- Circor reports Q4 adjusted EPS 77c vs. 46c last year
- 11/14/22
- Circor reports Q3 adjusted EPS 69c, consensus 34c
- 09/30/22
- Circor reports Q2 adjusted EPS 32c vs. 20c a year ago
- 03/15/23
- Babcock & Wilcox backs FY23 adjusted EBITDA view $100M-$120M
- 03/15/23
- Babcock & Wilcox reports Q4 EPS 2c, consensus 5c
- 11/08/22
- Babcock & Wilcox reports Q3 EPS (24c), consensus 2c
- 10/01/22
- SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says
- $116.29 /
-0.815 (-0.70%) - 12/05/22
- U.S, EU weigh tariffs on Chinese steel, aluminum, Bloomberg says
- 10/10/22
- Genius Sports, Sportradar settle data collection fight, EGR reports
- 02/16/23
- Beyond Meat, Oatly speculated as 'attractive' targets, Dealreporter says
- 03/09/23
- Credit Suisse regulatory compliance boss exits company, Reuters says
- 03/09/23
- Credit Suisse delay publication of annual report after SEC call, Reuters report
- 03/05/23
- Former top Credit Suisse shareholder sells full stake in bank, FT says
- 03/02/23
- Credit Suisse offers higher rates in Asia to woo wealthy clients, Reuters says
- 01/24/23
- Fly Intel: After-Hours Movers
- 11/10/22
- What You Missed On Wall Street On Thursday
- 11/10/22
- What You Missed On Wall Street This Morning
- $116.29 /
-0.815 (-0.70%) - 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 09/15/22
- What You Missed On Wall Street On Thursday
- 09/15/22
- What You Missed On Wall Street This Morning
- 02/03/23
- Bet On It: DraftKings layoffs could signal more emphasis on profitability
- 01/09/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/25/22
- Bet On It: DraftKings issue may impact user confidence more than their wallets
- 11/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- Fly Intel: After-Hours Movers
- 12/02/22
- What You Missed On Wall Street On Friday
- 12/02/22
- What You Missed On Wall Street This Morning
- 12/02/22
- Fly Intel: Pre-market Movers
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 01/18/23
- What You Missed On Wall Street This Morning
- 01/18/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 01/11/23
- What You Missed On Wall Street On Wednesday
- 01/11/23
- What You Missed On Wall Street This Morning
- 03/09/23
- What You Missed On Wall Street On Thursday
- 03/09/23
- What You Missed On Wall Street This Morning
- 03/02/23
- What You Missed On Wall Street This Morning
- 02/23/23
- What You Missed On Wall Street On Thursday
- 09/30/22
- What You Missed On Wall Street On Friday
- 09/30/22
- What You Missed On Wall Street This Morning
- $116.29 /
-0.815 (-0.70%) - 01/25/23
- Steel Dynamics options imply 3.0% move in share price post-earnings
- 10/19/22
- Steel Dynamics options imply 3.4% move in share price post-earnings
- 03/14/23
- Smartsheet options imply 10.5% move in share price post-earnings
- 12/01/22
- Smartsheet options imply 11.0% move in share price post-earnings
- 12/30/22
- Largest borrow rate increases among liquid names
- 12/19/22
- Largest borrow rate increases among liquid names
- 11/18/22
- Ebix call volume above normal and directionally bullish
- 11/08/22
- Largest borrow rate increases among liquid names
- 03/14/23
- Unusually active option classes on open March 14th
- 03/10/23
- Largest borrow rate increases among liquid names
- 01/26/23
- Unusually active option classes on open January 26th
- 12/15/22
- Largest borrow rate increases among liquid names
- 01/06/23
- Largest borrow rate increases among liquid names
- 01/05/23
- Largest borrow rate increases among liquid names
- 01/04/23
- Largest borrow rate increases among liquid names
|
Downgrade
|
Northland downgraded Luna… Northland downgraded Luna Innovations to Market Perform from Outperform with an unchanged price target of $8. Shares are up "significantly" since the firm's upgrade last May, and also since the company's Q3 report, noted the analyst. Given the "lowered and back end loaded" 2023 outlook and more leveraged balance sheet, the firm believes "the shares have gotten ahead of themselves," the analyst tells investors. ShowHide Related Items >><< - 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 03/14/23
- Luna Innovations sees FY23 revenue $125M-$130M, consensus $129.8M
- 03/14/23
- Luna Innovations sees Q1 revenue $23.0M-$25.0M, consensus $26.5M
- 03/14/23
- Luna Innovations reports Q4 EPS 8c, consensus 9c
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 03/14/23
- Fly Intel: After-Hours Movers
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 01/24/23
- Verastem reports interim data from Part A of the ongoing RAMP 201 Phase 2 study
- 10/04/22
- Verastem plans opening of RAMP 205 Phase 1b/2 clinical trial of VS-6766
- 03/14/23
- Vacasa says finished 2022 with 44K homes on platform, up 19% from 2021
- 01/24/23
- Vacasa to cut about 1,300 jobs or 17% of workforce, affirms Q4 guidance
- 10/02/22
- Fly Intel: Top five weekend stock stories
- 03/14/23
- Carl Icahn increases stake in Southwest Gas by $32M
- 03/10/23
- Icahn Enterprises raises Southwest Gas stake to 12.64% from 9.9%
- 12/15/22
- Williams to acquire MountainWest from Southwest Gas for $1.5B
- 12/15/22
- Southwest Gas implements corporate structure simplification
- 10/24/22
- Snap One acquires Parasol, terms undisclosed
- 03/14/23
- Smartsheet names Mike Gregoire board chair
- 12/02/22
- Smartsheet rises 15.6%
- 12/02/22
- Smartsheet rises 13.6%
- 12/01/22
- Smartsheet jumps 8% to $35.35 after Q3 earnings beat, guidance raise
- 03/07/23
- SentinelOne enters exclusive partnership with Wiz
- 01/17/23
- Crowdstrike adds two executives to its leadership team
- 01/12/23
- SentinelOne selected by JCDC to strengthen U.S. cybersecurity
- 12/06/22
- SentinelOne reports Q3 ARR up 106% to $487.4M
- 02/13/23
- Brainsway announces appointment of Beohm as new chairman
- 01/12/23
- Ormat Technologies secures financing agreement for Iien Geothermal Project
- 11/17/22
- Ormat Technologies falls -10.5%
- 11/17/22
- Ormat Technologies falls -9.1%
- 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 03/14/23
- Lennar sees Q2 new orders 16,000-17,000
- 01/19/23
- Redfin: Median U.S. home-sale price increased 0.9% for four weeks ending Jan. 15
- 12/15/22
- Lennar says postponing planned spin-off until more favorable conditions
- 12/15/22
- Lennar says inventory being 'carefully managed'
- 12/22/22
- Guess enters into $150M credit facility with five year term
- 02/14/23
- JANA Partners takes stake in Fidelity National, exits stake in Momentive Global
- 01/09/23
- Freshpet appoints Jay Dahlgren as EVP, manufacturing, technology, supply chain
- 11/14/22
- Jana made new buy Freshpet top holding in Q3, also bought Momentive
- 11/01/22
- Freshpet names Todd Cunfer as new CFO
- $39.60 /
+8.4101 (+26.96%) - 03/14/23
- First Republic rises 49.1%
- 03/14/23
- First Republic rises 42.0%
- 03/14/23
- First Republic rises 56.8%
- 03/14/23
- First Republic trading resumes
- 03/14/23
- Deciphera says FDA grants breakthrough therapy designation for QINLOCK
- 01/24/23
- Deciphera presents results from ctDNA analysis of INTRIGUE phase 3 stsudy
- 01/18/23
- Deciphera falls 8% to $19.00 after announcing $125M common stock offering
- 01/03/23
- Deciphera announces results from ctDNA analysis from Intrigue Phase 3 trial
- 03/14/23
- Casa Systems President and CEO Jerry Guo announces retiring March 17
- 03/14/23
- Beachbody reports Q4 total subscriptions at 2.17M, down 23.6% from last year
- 01/09/23
- Beachbody Company reiterates Q4 outlook
BLCM Bellicum Pharmaceuticals - 03/14/23
- Bellicum Pharmaceuticals trading resumes
- 03/14/23
- Bellicum Pharmaceuticals to discontinue GoCAR-T trials, evaluate alternatives
- 03/14/23
- Bellicum Pharmaceuticals trading halted, news pending
- 02/16/23
- Bellicum Pharmaceuticals presents early Phase 1 results for BPX-601
- 12/16/22 Barclays
- Smartsheet initiated with an Equal Weight at Barclays
- 12/12/22 RBC Capital
- Coupa Software upgraded to Sector Perform from Underperform at RBC Capital
- 12/02/22 DA Davidson
- Smartsheet price target raised to $45 from $40 at DA Davidson
- 12/02/22 RBC Capital
- Smartsheet price target raised to $36 from $32 at RBC Capital
SGTX Sigilon Therapeutics - $1.18 /
+0.4456 (+60.68%) - 01/18/23 Canaccord
- Sigilon Therapeutics initiated with a Buy at Canaccord
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 03/08/23 Deutsche Bank
- Crowdstrike price target raised to $130 from $115 at Deutsche Bank
- 03/06/23 Barclays
- SentinelOne price target lowered to $17 from $18 at Barclays
- 02/21/23 Wells Fargo
- Wells cuts SentinelOne to Equal Weight on concerns of declining demand trends
- 11/07/22 H.C. Wainwright
- Verastem price target lowered to $3 from $5 at H.C. Wainwright
- 10/05/22 BTIG
- Verastem price target lowered to $5 from $8 at BTIG
- 09/07/22 Alliance Global Partners
- Verastem resumed with a Buy at Alliance Global Partners
- 04/29/22 Cantor Fitzgerald
- Verastem assumed with an Overweight at Cantor Fitzgerald
- 03/01/23 Oppenheimer
- Lennar initiated with a Perform at Oppenheimer
- 02/14/23 BTIG
- Lennar price target raised to $116 from $104 at BTIG
- 01/13/23 RBC Capital
- Lennar downgraded to Underperform from Sector Perform at RBC Capital
- 01/11/23 BofA
- BofA upgrades trio of homebuilders, calls NVR top pick for 2023
- 01/25/23 TD Cowen
- Deciphera price target raised to $30 from $25 at Cowen
- 01/05/23 JonesResearch
- Deciphera upgraded to Hold from Sell at JonesResearch
- 01/04/23 Barclays
- Deciphera price target raised to $9 from $8 at Barclays
- 01/04/23 Guggenheim
- Deciphera upgraded to Buy from Neutral at Guggenheim
- $39.60 /
+8.4101 (+26.96%) - 03/14/23 Odeon Capital
- Odeon's Bove sees RBC making a run at First Republic
- 03/13/23 Compass Point
- First Republic downgraded to Neutral from Buy at Compass Point
- 03/13/23 BofA
- BofA removes rating on First Republic after SVB, Signature failures
- 03/13/23 JPMorgan
- First Republic selloff a 'dramatic overreaction,' says JPMorgan
- 02/07/23 JPMorgan
- Southwest Gas price target lowered to $75 from $78 at JPMorgan
- 12/14/22 Wells Fargo
- Southwest Gas price target raised to $73 from $66 at Wells Fargo
- 11/30/22 BofA
- Southwest Gas downgraded to Neutral at BofA as strategic review 'drags on'
- 11/30/22 BofA
- Southwest Gas downgraded to Neutral from Buy at BofA
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 11/11/22 JMP Securities
- Vacasa price target lowered to $5 from $7 at JMP Securities
- 11/10/22 JPMorgan
- Vacasa downgraded to Neutral on concerns into 2023 at JPMorgan
- 11/10/22 JPMorgan
- Vacasa downgraded to Neutral from Overweight at JPMorgan
- 10/31/22 Needham
- Vacasa price target lowered to $7 from $10 at Needham
- 05/05/22 Credit Suisse
- Beachbody Company initiated with a Neutral at Credit Suisse
- 03/29/22 BofA
- Beachbody Company initiated with a Neutral at BofA
- 05/26/22 B. Riley
- Guess price target lowered to $29 from $36 at B. Riley
- 03/17/22 B. Riley
- Guess price target lowered to $36 from $38 at B. Riley
- 11/11/22 BMO Capital
- Snap One price target lowered to $12 from $17 at BMO Capital
- 10/17/22 Morgan Stanley
- Snap One price target lowered to $13 from $16 at Morgan Stanley
- 08/15/22 BMO Capital
- Snap One price target lowered to $17 from $21 at BMO Capital
- 05/18/22 UBS
- Snap One price target lowered to $19 from $24 at UBS
- 01/17/23 Northland
- Casa Systems upgraded to Outperform from Market Perform at Northland
- 11/04/22 Barclays
- Casa Systems downgraded to Equal Weight from Overweight at Barclays
- 08/08/22 Northland
- Casa Systems downgraded at Northland after mixed Q2, guidance suspension
- 08/08/22 Northland
- Casa Systems downgraded to Market Perform from Outperform at Northland
BLCM Bellicum Pharmaceuticals - 02/28/23 Truist
- Freshpet price target raised to $55 from $40 at Truist
- 02/28/23 Baird
- Freshpet price target raised to $75 from $70 at Baird
- 02/28/23 Credit Suisse
- Freshpet price target raised to $65 from $60 at Credit Suisse
- 02/09/23 Bernstein
- Bernstein ponders takeover targets for J.M. Smucker after pet food sale
- 03/01/23 UBS
- UBS upgrades Ormat to Buy on multiple growth tailwinds
- 03/01/23 UBS
- Ormat Technologies upgraded to Buy from Neutral at UBS
- 02/27/23 Roth MKM
- Ormat Technologies price target lowered to $93 from $104 at Roth MKM
- 11/22/22 BofA
- Ormat Technologies reinstated with a Neutral at BofA
- 03/14/23
- Verastem reports Q4 EPS (8c), consensus (10c)
- 11/03/22
- Verastem reports Q3 EPS (8c), consensus (12c)
- 03/14/23
- Vacasa sees FY23 revenue down mid to high single digits
- 03/14/23
- Vacasa sees Q1 revenue $230M-$240M, consensus $264.8M
- 03/14/23
- Vacasa reports Q4 EPS (70c), consensus (38c)
- 11/09/22
- Vacasa reports Q3 EPS 4c, consensus 7c
- 02/28/23
- Southwest Gas reports Q4 adjusted EPS $1.16, consensus $1.58
- 11/09/22
- Southwest Gas reports Q3 adjusted EPS (5c), consensus 27c
- 03/14/23
- Snap One sees FY23 revenue $1.05B-$1.09B, consensus $1.08B
- 03/14/23
- Snap One reports Q4 EPS (5c), consensus 11c
- 11/09/22
- Snap One sees FY revenue $1.1B-$1.115B, consensus $1.17B
- 11/09/22
- Snap One reports Q3 EPS (1c), consensus 26c
- 03/14/23
- Smartsheet sees FY24 adjusted EPS 31c-38c, consensus (9c)
- 03/14/23
- Smartsheet sees Q1 adjusted EPS 8c-9c, consensus (6c)
- 03/14/23
- Smartsheet reports Q4 adjusted EPS 7c, consensus (1c)
- 03/14/23
- Notable companies reporting after market close
SGTX Sigilon Therapeutics - $1.18 /
+0.4456 (+60.68%) - 03/14/23
- Sigilon Therapeutics reports Q4 EPS (21c), consensus (38c)
- 11/10/22
- Sigilon Therapeutics reports Q3 EPS (27c), consensus (42c)
- 03/14/23
- SentinelOne sees FY24 revenue $631M-$640M, consensus $648.66M
- 03/14/23
- SentinelOne sees Q1 revenue $137M, consensus $136.85M
- 03/14/23
- SentinelOne reports Q4 adjusted EPS (13c), consensus (16c)
- 02/22/23
- Ormat Technologies sees FY23 revenue $823M-$858M, consensus $865.61M
- 02/22/23
- Ormat Technologies reports Q4 adjusted EPS 73c vs 41c last year
- 11/02/22
- Ormat Technologies narrows FY22 revenue view to $720M-$735M from $710M-$735M
- 11/02/22
- Ormat Technologies reports Q3 adjusted EPS 33c, consensus 26c
- 03/14/23
- Luna Innovations sees FY23 revenue $125M-$130M, consensus $129.8M
- 03/14/23
- Luna Innovations sees Q1 revenue $23.0M-$25.0M, consensus $26.5M
- 03/14/23
- Luna Innovations reports Q4 EPS 8c, consensus 9c
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 03/14/23
- Lennar reports Q1 EPS $2.06, consensus $1.55
- 12/15/22
- Lennar sees Q1 EPS $1.40-$1.70, consensus $2.40
- 12/14/22
- Lennar reports Q4 adjusted EPS $5.02, consensus $4.89
- 03/14/23
- Guess sees FY24 adjusted EPS $2.45-$2.80, two estimates $3.40
- 03/14/23
- Guess sees Q1 adjusted EPS (31c)-(25c), two estimates 52c
- 03/14/23
- Guess reports Q4 adjusted EPS $1.74, two estimates $1.30
- 11/22/22
- Guess sees FY23 adjusted EPS $2.35, two estimates $2.63
- 02/27/23
- Freshpet sees 2023 net sales about $750M, consensus $755.01M
- 02/27/23
- Freshpet reports Q4 EPS (6c), consensus (9c)
- 01/09/23
- Freshpet reiterates 2022 net sales guidance
- 11/01/22
- Freshpet sees 2022 net sales greater than $575M, consensus $579.48M
- $39.60 /
+8.4101 (+26.96%) - 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 02/07/23
- Deciphera reports Q4 EPS (60c), consensus (56c)
- 01/03/23
- Deciphera sees FY22 revenue roughly $134M, consensus $132.52M
- 01/03/23
- Deciphera sees Q4 revenue roughly $36M, consensus $34.83M
- 11/03/22
- Deciphera reports Q3 EPS (55c), consensus (58c)
- 03/14/23
- Casa Systems reports Q4 EPS 5c, one estimate (7c)
- 01/31/23
- Casa Systems sees Q4 revenue $83M-$84M
- 11/04/22
- Casa Systems reports Q3 EPS (29c) vs. (5c) a year ago
- 03/14/23
- Beachbody Company reports Q4 EPS (15c), consensus (10c)
- 11/09/22
- Beachbody Company sees Q4 revenue $140M-$150M, consensus $157.16M
- 11/09/22
- Beachbody Company reports Q3 EPS (11c), consensus (13c)
|
Earnings
|
Sees FY23 adjusted EBITDA… Sees FY23 adjusted EBITDA of $14M-$18M vs. $12.1M in FY22. ShowHide Related Items >><< - 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 03/14/23
- Luna Innovations sees Q1 revenue $23.0M-$25.0M, consensus $26.5M
- 03/14/23
- Luna Innovations reports Q4 EPS 8c, consensus 9c
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 11/10/22
- Luna Innovations reports Q3 adjusted EPS 9c, consensus 6c
|
Earnings
| ShowHide Related Items >><< - 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 03/14/23
- Luna Innovations reports Q4 EPS 8c, consensus 9c
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 11/10/22
- Luna Innovations reports Q3 adjusted EPS 9c, consensus 6c
|
Earnings
|
Reports Q4 revenue… Reports Q4 revenue $31.7M, consensus $32.4M. CEO Scott Graeff says: "2022 was a transformational year for Luna representing the culmination of execution on the five-year strategic plan we outlined in 2017, thereby creating a pure-play fiber optics company. We've moved into FY23 with keen focus and high expectations for organizational optimization, large customer wins, and market expansion. With the completed divestiture of Luna Labs, our acquisition of Lios Sensing, and the integration of OptaSense, we created a solid base that reflects our fiber-focused vision for our business going forward. We believe these accomplishments will help us deliver strong financial results in FY23 and will enable our success far into the future. We are creating a leading global organization with world-class capabilities. With the right people in the right places in a right-sized organization, we are preparing for significant scalability and targeting meaningful growth. We are looking forward to a strong year in an expanding market with incredible potential." ShowHide Related Items >><< - 12/21/22
- Luna Innovations recently awarded contract with PT Freeport Indonesia
- 12/07/22
- Luna secures $3M Northrop Grumman order for OBR 6200 reflectometer
- 09/22/22
- Luna Innovations announces new $14.2M supply contract with Intuitive Surgical
- 11/11/22 B. Riley
- Luna Innovations price target lowered to $9.50 from $11.50 at B. Riley
- 05/23/22 Northland
- Luna Innovations upgraded to Outperform from Market Perform at Northland
- 05/17/22 B. Riley
- Luna Innovations price target lowered to $11.50 from $12 at B. Riley
- 11/10/22
- Luna Innovations backs FY22 revenue view $109M-$115M, consensus $112.25M
- 11/10/22
- Luna Innovations reports Q3 adjusted EPS 9c, consensus 6c
|
Recommendations
|
Raymond James analyst… Raymond James analyst Simon Leopold lowered the firm's price target on Coherent to $74 from $76 and keeps an Outperform rating on the shares. Coherent is well positioned across many market opportunities, but in the intermediate term, its largest segment, Networking at ~45% of sales, faces slowing as some customers absorb inventory, the analyst tells investors in a research note. ShowHide Related Items >><< - 02/23/23
- Coherent begins trading on NYSE
- 02/08/23
- Coherent transfer listing to NYSE from Nasdaq
- 10/18/22
- Coherent appoints Julie Sheridan Eng as Chief Technology Officer
- 10/17/22
- Windstream partners with Coherent, Nokia for 400 Gig networking
- 03/02/23 BofA
- BofA keeps Buy on ON, says supply agreements offset premature Tesla SiC claims
- 02/09/23 TD Cowen
- Coherent price target lowered to $87 from $95 at Cowen
- 02/09/23 Susquehanna
- Coherent price target raised to $45 from $42 at Susquehanna
- 01/23/23 Barclays
- Coherent price target raised to $36 from $30 at Barclays
- 11/09/22
- Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B
- 11/09/22
- Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c
- 11/09/22
- Coherent reports Q1 adjusted EPS $1.04, consensus 83c
- 03/02/23
- Why are these three stocks sinking after Tesla's investor day?
- 11/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
|
Conference/Events
|
Meeting to be held in San… Meeting to be held in San Diego on March 8 hosted by Craig Hallum. ShowHide Related Items >><< - 02/23/23
- Coherent begins trading on NYSE
- 02/08/23
- Coherent transfer listing to NYSE from Nasdaq
- 10/18/22
- Coherent appoints Julie Sheridan Eng as Chief Technology Officer
- 10/17/22
- Windstream partners with Coherent, Nokia for 400 Gig networking
- 03/02/23 BofA
- BofA keeps Buy on ON, says supply agreements offset premature Tesla SiC claims
- 02/09/23 TD Cowen
- Coherent price target lowered to $87 from $95 at Cowen
- 02/09/23 Susquehanna
- Coherent price target raised to $45 from $42 at Susquehanna
- 01/23/23 Barclays
- Coherent price target raised to $36 from $30 at Barclays
- 11/09/22
- Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B
- 11/09/22
- Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c
- 11/09/22
- Coherent reports Q1 adjusted EPS $1.04, consensus 83c
- 03/02/23
- Why are these three stocks sinking after Tesla's investor day?
- 11/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- 09/08/22
- Four new option listings and two option delistings on September 8th
|
Conference/Events
|
Meeting to be held in San… Meeting to be held in San Diego on March 8 hosted by Loop. ShowHide Related Items >><< - 02/23/23
- Coherent begins trading on NYSE
- 02/08/23
- Coherent transfer listing to NYSE from Nasdaq
- 10/18/22
- Coherent appoints Julie Sheridan Eng as Chief Technology Officer
- 10/17/22
- Windstream partners with Coherent, Nokia for 400 Gig networking
- 03/02/23 BofA
- BofA keeps Buy on ON, says supply agreements offset premature Tesla SiC claims
- 02/09/23 TD Cowen
- Coherent price target lowered to $87 from $95 at Cowen
- 02/09/23 Susquehanna
- Coherent price target raised to $45 from $42 at Susquehanna
- 01/23/23 Barclays
- Coherent price target raised to $36 from $30 at Barclays
- 11/09/22
- Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B
- 11/09/22
- Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c
- 11/09/22
- Coherent reports Q1 adjusted EPS $1.04, consensus 83c
- 03/02/23
- Why are these three stocks sinking after Tesla's investor day?
- 11/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- 09/08/22
- Four new option listings and two option delistings on September 8th
|